Midgard Science
SC

Sus Clinicals

Cincinnati, OH, United States susclinicals.com From their website, Nov 2026

  • AAALAC

Work here? Claim this listing

About

Sus Clinicals develops and provides the Oncopig® large-animal cancer research platform for cancer therapeutics, devices, and diagnostics. It works with academic and industry clients and with CRO partners to generate predictive preclinical data from tumor models and other disease models. The company is based in Cincinnati, Ohio, with scientific work in Chicago, Illinois and lab facilities in Urbana, Illinois.

Services

  • Oncopig® platform research programs

    Designs and supports customized preclinical research programs using the Oncopig platform to generate predictive data for therapeutics, devices, and diagnostics.

  • CRO partnership model

    Works through qualified CRO partners to design, execute, document, and manage Oncopig studies with regulatory compliance support.

  • Direct Oncopig supply

    Provides Oncopigs directly to academic and industry clients with established animal research facilities.

  • Tumor induction training

    Provides training on tumor induction methodologies for clients using Oncopigs in their own facilities.

  • Methodology guidance and consultation

    Offers guidance and consultation on Oncopig study methods and research implementation.

  • On-site technical assistance

    Provides on-site technical assistance upon request for Oncopig-based research.

  • European Oncopig research services

    Delivers localized Oncopig research services in Europe through a partnership with Versa Biomedical in Barcelona.

  • Oncopig® preclinical cancer research

    Designs and supports preclinical research programs using the Oncopig platform for predictive cancer studies.

3 more services
  • European research services
  • Tumor induction methodology support
  • Customized preclinical testing
Turnaround
Approximately two weeks

Capabilities

Assays and studies
  • Antibodies
  • ADCs
  • Tumor induction
  • Safety assessment
  • Efficacy assessment
  • Metabolic assessment
11 more
  • Biodistribution
  • Imaging
  • Ablation
  • Drug delivery testing
  • Preclinical testing
  • Predictive preclinical data
  • Safety testing
  • Efficacy testing
  • Metabolic effects testing
  • Imaging-based assessment
  • Liquid biopsy
Scale and capacity
  • Large-animal testing
  • Multiple induction sites in each animal
  • Approximately 2 weeks to tumor formation
Therapeutic areas
  • Oncology
  • Liver cancer
  • Lung cancer
  • Colon cancer
  • Bladder cancer
  • Brain cancer
  • Kidney cancer

Modalities and species

Modalities
  • Antibody
  • ADC
Species and models
  • Oncopig®
  • Porcine lung cancer model
  • Porcine hepatocellular carcinoma
  • Glioma
  • Kidney model
  • Colon model
11 more
  • Bladder model
  • Transgenic large animal
  • Liver
  • Lung
  • Pancreas
  • Bladder
  • Colorectal
  • Kidney
  • Brain
  • Soft tissue
  • Hepatocellular carcinoma

Certifications

As the company states them, with the certificate or registry record where there is one.

  • AAALACSelf-reported

    Scope: research partners and facilities

Industries served

  • Academic research
  • Pharmaceuticals
  • Medical devices
  • Diagnostics

Details

Address
4555 Lake Forest Drive Suite 650 Cincinnati, OH 45242-3789
Sites
  • Chicago, United States
  • Urbana, United States
  • Barcelona, Spain
Serves
Europe

Similar labs